Literature DB >> 19749400

The spectrum series: grappling with the overlap between Alzheimer's and Parkinson's diseases. 9th International Conference on Alzheimer's and Parkinson's Diseases, 11-15 March 2009, Prague,Czech Republic.

Gabrielle Strobel1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19749400     DOI: 10.3233/JAD-2009-1234

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


× No keyword cloud information.
  9 in total

1.  The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen.

Authors:  Jack T Rogers; Sohan Mikkilineni; Ippolita Cantuti-Castelvetri; Deborah H Smith; Xudong Huang; Sanghamitra Bandyopadhyay; Catherine M Cahill; Maria L Maccecchini; Debomoy K Lahiri; Nigel H Greig
Journal:  J Neural Transm (Vienna)       Date:  2011-01-08       Impact factor: 3.575

2.  The topography of brain damage at different stages of Parkinson's disease.

Authors:  Federica Agosta; Elisa Canu; Tanja Stojković; Michela Pievani; Aleksandra Tomić; Lidia Sarro; Nataša Dragašević; Massimiliano Copetti; Giancarlo Comi; Vladimir S Kostić; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2012-04-24       Impact factor: 5.038

3.  Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera.

Authors:  Eric Nagele; Min Han; Cassandra Demarshall; Benjamin Belinka; Robert Nagele
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

4.  Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera.

Authors:  Min Han; Eric Nagele; Cassandra DeMarshall; Nimish Acharya; Robert Nagele
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

Review 5.  Interaction between pathogenic proteins in neurodegenerative disorders.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

6.  Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns.

Authors:  J V Sanchez-Mut; H Heyn; E Vidal; S Moran; S Sayols; R Delgado-Morales; M D Schultz; B Ansoleaga; P Garcia-Esparcia; M Pons-Espinal; M M de Lagran; J Dopazo; A Rabano; J Avila; M Dierssen; I Lott; I Ferrer; J R Ecker; M Esteller
Journal:  Transl Psychiatry       Date:  2016-01-19       Impact factor: 6.222

7.  Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk.

Authors:  Valentina Moskvina; Denise Harold; GianCarlo Russo; Alexey Vedernikov; Manu Sharma; Mohamed Saad; Peter Holmans; Jose M Bras; Francesco Bettella; Margaux F Keller; Nayia Nicolaou; Javier Simón-Sánchez; J Raphael Gibbs; Claudia Schulte; Alexandra Durr; Rita Guerreiro; Dena Hernandez; Alexis Brice; Hreinn Stefánsson; Kari Majamaa; Thomas Gasser; Peter Heutink; Nick Wood; Maria Martinez; Andrew B Singleton; Michael A Nalls; John Hardy; Michael J Owen; Michael C O'Donovan; Julie Williams; Huw R Morris; Nigel M Williams
Journal:  JAMA Neurol       Date:  2013-10       Impact factor: 18.302

Review 8.  Basic mechanisms of neurodegeneration: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2010-01-11       Impact factor: 5.310

9.  DNA Methylation in Neurodegenerative and Cerebrovascular Disorders.

Authors:  Olaia Martínez-Iglesias; Iván Carrera; Juan Carlos Carril; Lucía Fernández-Novoa; Natalia Cacabelos; Ramón Cacabelos
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.